XWXin Wang

Xin Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xin Wang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Deep Learning Model to Predict Breast Cancer Recurrence Using Longitudinal Mammograms and Clinical Data

    by Chunyao Lu, Xin Wang, Tianyu Zhang, Xinglong Liang, Luyi Han, Miguel Braga, Carla Sitges, Zahra Aghdam, Yuan Gao, Antonio Portaluri, et al.

    MultiModalNet, a deep learning model that combines longitudinal mammograms and clinical data, was developed to predict breast cancer recurrence and recurrence subtype, outperforming traditional methods.

  • Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy

    by Luyi Han, Tao Tan, Tianyu Zhang, Yuan Gao, Xin Wang, Valentina Longo, Sofía Ventura-Díaz, Anna D'ANgelo, Yue Sun, Jonas Teuwen, et al.

    The proposed registration framework improved global alignment while preserving tumor volume in longitudinal dynamic contrast-enhanced breast MRI and enabled a registration-based biomarker for predicting response to neoadjuvant chemotherapy.


  • Open Access

    Decoding Tumor Phenotypes: A Radiologist-Inspired Deep Learning Framework for Breast Cancer Recurrence Prediction

    by Tao Tan, Chunyao Lu, Tianyu Zhang, Xinglong Liang, Antonio Portaluri, Luyi Han, Yaqian Chen, Nika Rasoolzadeh, Ruixiang Qi, Yuan Gao, et al.

    Accurate prognostication in breast cancer remains constrained by the limited resolution of conventional clinicopathological markers, often leading to overtreatment of indolent disease or missed opportunities for intensified therapy in aggressive cases. Here we present a radiologist-inspired multimodal deep learning framework that integrates whole-volume dynamic contrast-enhanced MRI (DCE-MRI), radiology reports and clinical variables to predict recurrence-free survival. The model is trained through cross-modal semantic alignment, in which report-derived representations guide the learning of prognostic imaging features. In a large development cohort from the Netherlands Cancer Institute (NKI, n = 3,266), the framework achieved strong discrimination (C-index 0.727) and identified high-risk patients with a hazard ratio of 7.32 (P < 0.0001). Robustness was further assessed in two independent public external cohorts (Duke and I-SPY 1; n = 1,054) using text-free inference, where the model maintained consistent performance (C-index 0.702 and 0.697, respectively). Prognostic accuracy remained stable across both short- and long-term horizons, with high discriminative power from 2 to 12 years after treatment (AUC 0.77–0.83). This temporal stability enabled reliable identification of ultra-low-risk subgroups (5-year Recurrence-free survival > 95%) as well as early detection of aggressive phenotypes prone to early recurrence. These findings support semantically guided multimodal learning as an interpretable and operationally robust imaging biomarker for personalized breast cancer management.

  • Incorporating global-local tissue changes to predict future breast cancer from longitudinal screening mammograms

    by Xin Wang, Tao Tan, Yuan Gao, Eric Marcus, Hong-Yu Zhou, Chunyao Lu, Luyi Han, Antonio Portaluri, Ruisheng Su, Tianyu Zhang, et al.


  • Visualizing Radiologic Connections: An Explainable Coarse-to-Fine Foundation Model with Multiview Mammograms and Associated Reports

    by Yuan Gao, Hong-Yu Zhou, Xin Wang, Antonio Portaluri, Tianyu Zhang, Regina Beets-Tan, Luyi Han, Chunyao Lu, Laura Estacio, Anna D’aNgelo, et al.

    The proposed explainable pretraining framework for multiview mammograms and associated reports demonstrated high label efficiency in malignancy recognition, segmentation, and localization across four external public datasets.


  • Open Access

    Mammo-AGE: deep learning estimation of breast age from mammograms

    by Xin Wang, Tao Tan, Yuan Gao, Hong-Yu Zhou, Tianyu Zhang, Luyi Han, Antonio Portaluri, Eric Marcus, Chunyao Lu, Caroline A. Drukker, et al.

    Biological age is an important indicator of organ functions and health. Although mammograms are widely used in breast cancer screening, the potential of mammogram-based biological age predictors remains underexplored. Here, we propose a deep learning model to estimate the biological age of the breast using healthy mammograms. The model is developed on three large datasets and externally validated on two additional datasets, encompassing 95,826 mammograms from 44,497 women aged 18 to 98 years. It demonstrates accurate age estimation (mean absolute error: 4.2 − 6.1 years) with strong correlation to chronological age. Predicted breast age stratifies breast cancer risk similarly to chronological age. Occlusion analysis, employed for model interpretation, reveals the aging-related pattern of the breast. The breast age gap (the difference between system-bias-corrected breast age and chronological age) may reflect breast health status. Breast cancer patients show higher breast age gaps than the healthy population. In two longitudinal datasets, larger breast age gaps are associated with increased future breast cancer risk, with hazard ratios of 1.013 − 1.022. Furthermore, we finetune the model specifically for downstream breast cancer diagnosis and risk prediction. Our approach outperforms other comparative methods, showing its potential for supporting both early detection and personalized screening strategies.


  • Open Access

    Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history

    by Xin Wang, Tao Tan, Yuan Gao, Ruisheng Su, Jonas Teuwen, Jaap Kroes, Tianyu Zhang, Anna D’aNgelo, Luyi Han, Caroline A. Drukker, et al.

    Breast cancer (BC) risk assessment aims to enhance individualized screening and prevention strategies. While recent deep learning (DL) models based on mammography have shown promise in short-term risk prediction, they primarily rely on single-time-point (STP) exams, ignoring temporal changes in breast tissue from sequence exams. We present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel DL approach that integrates traditional risk factors and longitudinal mammography data to capture subtle tissue changes indicative of future malignancy. Using a large in-house dataset with 171,168 mammograms from 9133 women, MTP-BCR achieved superior performance in 10-year risk prediction, with an AUC of 0.80 (95% CI, 0.78–0.82) at the patient level, outperforming STP-based and traditional risk models. External validation on the CSAW-CC dataset confirmed its robustness. Further analysis demonstrates the advantages of the MTP-BCR method in diverse populations. MTP-BCR also excels in risk stratification and offers heatmaps to enhance clinical interpretability.


  • Top Cited Papers
    Open Access

    An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer

    by Yuan Gao, Sofia Ventura-Diaz, Xin Wang, Muzhen He, Zeyan Xu, Arlene Weir, Hong-Yu Zhou, Tianyu Zhang, Frederieke H. van Duijnhoven, Luyi Han, et al.

    Multi-modal image analysis using deep learning (DL) lays the foundation for neoadjuvant treatment (NAT) response monitoring. However, existing methods prioritize extracting multi-modal features to enhance predictive performance, with limited consideration on real-world clinical applicability, particularly in longitudinal NAT scenarios with multi-modal data. Here, we propose the Multi-modal Response Prediction (MRP) system, designed to mimic real-world physician assessments of NAT responses in breast cancer. To enhance feasibility, MRP integrates cross-modal knowledge mining and temporal information embedding strategy to handle missing modalities and remain less affected by different NAT settings. We validated MRP through multi-center studies and multinational reader studies. MRP exhibited comparable robustness to breast radiologists, outperforming humans in predicting pathological complete response in the Pre-NAT phase (ΔAUROC 14% and 10% on in-house and external datasets, respectively). Furthermore, we assessed MRP’s clinical utility impact on treatment decision-making. MRP may have profound implications for enrolment into NAT trials and determining surgery extensiveness.


  • Open Access

    Predicting long term breast cancer risk using longitudinal mammographic screening history

    by Tao Tan, Xin Wang, Yuan Gao, Ruisheng Su, Tianyu Zhang, Luyi Han, Jonas Teuwen, Jaap Kroes, Anna D'Angelo, Caroline Drukker, et al.

    Risk assessment of breast cancer (BC) seeks to enhance individualized screening and prevention strategies. Recent deep learning (DL) risk models based on mammography have shown superiority in short-term risk prediction compared to traditional risk factor-based models. However, these models primarily rely on single-time exams, which emphasize the detection of existing lesions and may ignore the temporal changes in breast tissues. In this study, we present the Multi-Time Point Breast Cancer Risk Model (MTP-BCR), a novel temporospatial DL risk model that integrates traditional BC risk factors and longitudinal mammography data to identify subtle changes in breast tissue indicative of future malignancy. Utilizing a large inhouse dataset comprising risk factors and 171,168 mammograms involving 9,133 women, we evaluate the performance of the MTP-BCR model in long-term risk prediction. Our model demonstrates a significant improvement in 10-year risk prediction with an area under the receiver operating characteristics (AUC) of 0.80, outperforming the traditional BCSC 10-year risk model, our pure image model (without risk factors), and is also superior to other SOTA methods at 5-year AUC in various screening cohorts. Furthermore, MTP-BCR provides unilateral breast-level predictions with AUCs up to 0.81 and 0.77 for 5-year and 10-year risk assessments, respectively. External validation in the public CSAW-CC dataset demonstrates the consistent advantage of our multi-time point-based model compared to the single-time point-based method. For the prediction of breast cancer recurrence, our MTP-BCR obtains a 5-year AUC of 0.71 which also surpasses other methods. The heatmaps derived from our model may help clinicians better understand the progression from normal tissue to cancerous growth, enhancing interpretability in breast cancer risk assessment.